Pantarhei Bioscience started its activities on January 1, 2001. The company operates as a virtual organisation employing top-executives, who recruit new projects and manage the outsourcing of all activities. (Corporate)

Drug development by Pantarhei Bioscience is characterised by the innovative use of existing compounds. New treatments developed by Pantarhei Bioscience will be safe, address obvious medical needs and have clear medical advantages.Pantarhei Bioscience is specialised in the clinical development of new drugs for the treatment of gender-related diseases. Gender-related Medicine includes diseases and medical treatments that differ in females and males.

Pantarhei has developed a mature clinical pipeline. (Pipeline)

The use of existing compounds i.e. biologicals, hormones and approved drugs or combinations thereof allows fast and cost-effective clinical drug development. (Progress)

At present 52 patents and patent applications are in different stages of processing. Preclinical and clinical studies supporting the new treatment concepts are ongoing.

Successfully patented concepts that are supported by (clinical) data are licensed out to pharmaceutical companies for final clinical development and commercialisation. (Partnering)